Rein Therapeutics Inc.
RNTXHealthcare|Biotechnology|US
$0.61
+0.00 (+0.28%)
Cash / Share
$1.34
Clinical Trials (11)
| Trial | Conditions | Phase | Status | Enrollment | Design | Drug |
|---|---|---|---|---|---|---|
| NCT06364631 CARE1 Pragmatic Clinical Trial | Metastatic Kidney Cancer, Metastatic Kidney Carcinoma | P3 | Recruiting | 1,250 | RCT, Open-label | Nivolumab, Ipilimumab, Pembrolizumab, Cabozantinib, Axitinib, Lenvatinib |
| NCT06968845 A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis | Idiopathic Pulmonary Fibrosis (IPF) | P2 | Recruiting | 120 | RCT, Double-blind | LTI-03, Placebo |
| NCT06257134 Impact on Quality of Life of Symptoms Routine E-monitoring Among Dialysis Patients. | End Stage Renal Disease | N/A | Recruiting | 2,293 | RCT, Open-label | — |
| NCT04159831 A Study to Evaluate LTI-01 in Patients With Infected, Non-draining Pleural Effusions | Pleural Effusion | P2 | Completed | 44 | RCT, Double-blind | LTI-01, Placebo |
| NCT04233814 Safety, Tolerability and Pharmacokinetic Study of LTI-03 in Healthy Adult Subjects | Idiopathic Pulmonary Fibrosis | P1 | Completed | 71 | RCT, Double-blind | Caveolin-1-Scaffolding-Protein-Derived Peptide (LTI-03), Placebo |
| NCT05954988 A Study to Evaluate LTI-03 in Newly Diagnosed Idiopathic Pulmonary Fibrosis (IPF) Patients | Idiopathic Pulmonary Fibrosis | P1 | Completed | 24 | RCT, Double-blind | LTI-03, Placebo |
| NCT01845012 Evaluation of Daily HemoDialysis at Low Dialysate Flow in Patients Previously Treated With Conventional Hemodialysis | End Stage Renal Disease | N/A | Terminated | 2 | Open-label | — |
| NCT06219798 Evaluation of a Pathway on the Evolution of Renal Function in Patients With Advanced Chronic Kidney Disease | Kidney Function Issue | Unknown | 300 | — | — | |
| NCT01114789 Impact on the Proteolysis of Obesity in Dialysis | Hemodialysis Patients | N/A | Unknown | 40 | Open-label | — |
| NCT05154708 Impact of the Routine Collection of Symptoms on Quality of Life in Dialysis Patients | Patients Reported Outcomes | Terminated | 65 | — | — | |
| NCT07729358 Evaluation of the Effect of Light Therapy on the Evolution of Self-reported Depressive Disorders in Chronic Hemodialysis Patients | End-stage Chronic Kidney Disease Treated With Hemodialysis, Depressive Disorders | N/A | Not Yet Recruiting | 340 | RCT, Double-blind | — |